For years, the drug development process has been slow and steady — sometimes painfully so — with a mean timeline of 10 years between a drug’s clinical testing and its approval. Then the COVID-19 pandemic hit and Pfizer received an emergency use authorization for the vaccine less than a year after the virus was identified.